logo
ProjectCompleted

Fosun Pharma

One of 10,000+ projects Taiyo tracks in China.

Source: International Finance Corporation (IFC)

Fosun Pharma Group is a leading Chinese pharmaceutical group focused on research, development, production and distribution of pharmaceutical products in China. The Group currently develops, manufactures and sells over 190 formulations and 20 different types of Active Pharmaceutical Ingredients (APIs). Its products have leading market positions in the treatment of gynecological and hepatic diseases

Status
Closed
Sector
Waste Processing and Treatment, Manufacturing (Industrial), Water Supply and Storage, Hospital, Government
Location
China
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Fosun Pharma

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Fosun Pharma” is an infrastructure initiative in the Waste Processing and Treatment sector, located in China. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

completed

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Fosun Pharma Group is a leading Chinese pharmaceutical group focused on research, development, production and distribution of pharmaceutical products in China. The Group currently develops, manufactures and sells over 190 formulations and 20 different types of Active Pharmaceutical Ingredients (APIs). Its products have leading market positions in the treatment of gynecological and hepatic diseases, diabetes, and malaria. The Group has 46 production lines at 13 production sites in different parts of China including Chongqing, Guangxi, Jiangsu, Shanghai and Hebei. All of the Group’s pharmaceutical production facilities are GMP (Good Manufacturing Practice) compliant. Fosun Pharma also possesses one of the largest wholesale and retail distribution networks for pharmaceutical products in China. In 2003, Fosun Pharma made a strategic decision to acquire a 49% stake in Sinopharm Medicine Holding Co., Ltd. (Sinopharm). Sinopharm is the biggest wholesaler/retailer network in China. In major Chinese cities, such as Beijing, Shanghai and Shenzhen, Fosun Pharma and Sinopharm have a total of 1,500 pharmacies and rank among the top 3 players in each city. This project aims to support Fosun’s operating activities in the next 12–18 months.

Original sector

FA - Pharmaceuticals and Medicine

Location

Country

China

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Waste Processing and Treatment, Manufacturing (Industrial), Water Supply and Storage, Hospital, Government

Article published date

2025-08-08

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project